{
  "query": "Explain mechanisms of immunotherapy resistance",
  "response": "Primary resistance mechanisms: loss of antigen presentation (β2M mutations), defects in IFN-γ signaling (JAK1/2 mutations), and T-cell exclusion. Acquired resistance: selection of antigen-loss variants, upregulation of alternative checkpoints (TIM-3, LAG-3), and epithelial-mesenchymal transition.",
  "attention": {
    "sources": [
      "resistance-mechanisms.pdf",
      "tumor-evolution.pdf"
    ],
    "weights": [
      0.7,
      0.3
    ],
    "patterns": [
      "sources:2",
      "outcome:success"
    ]
  },
  "outcome": "success",
  "confidence": 0.88,
  "timestamp": 1760058208798,
  "memory_type": "long-term",
  "id": "b86db20feaa4654c69785a8400b7d3f276fe20bb59806645ae96b5edfd168072"
}